innoscripta SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	85.92	64.71	39.37	27.27	19.83
Revenue Growth (YoY)	215.02%	64.34%	44.36%	37.56%	-
Cost of Revenue	24.62	19.42	18.19	13.29	8.71
Gross Profit	61.3	45.29	21.19	13.98	11.11
Other Operating Expenses	10.39	7.78	5.48	4.68	3.13
Operating Expenses	10.62	7.96	5.63	4.84	3.26
Operating Income	50.68	37.32	15.56	9.15	7.86
Interest Expense	-0.07	-0.09	-0.08	-0.06	-0.21
Interest & Investment Income	0.18	0.23	0.06	0.12	0.01
Currency Exchange Gain (Loss)	-0.07	-0.05	-0.09	0.03	-0
Pretax Income	50.71	37.41	15.45	9.24	7.66
Income Tax Expense	16.77	12.32	5.18	3.15	2.57
Net Income	33.93	25.09	10.27	6.1	5.09
Net Income to Common	33.93	25.09	10.27	6.1	5.09
Net Income Growth	456.56%	144.27%	68.46%	19.88%	-
Shares Outstanding (Basic)	10	10	10	0	-
Shares Outstanding (Diluted)	10	10	10	0	-
Shares Change (YoY)	39900.00%	-	39900.00%	-	-
EPS (Basic)	3.39	2.51	1.03	243.89	-
EPS (Diluted)	3.39	2.51	1.03	243.89	-
EPS Growth	-98.61%	144.27%	-99.58%	-	-
Free Cash Flow	36.53	20	5.15	8.56	-0.59
Free Cash Flow Per Share	3.65	2.00	0.52	342.41	-
Dividend Per Share	2.400	2.400	1.600	200.000	-
Dividend Growth	-98.80%	50.00%	-99.20%	-	-
Gross Margin	71.34%	69.99%	53.81%	51.27%	56.05%
Operating Margin	58.98%	57.68%	39.52%	33.54%	39.63%
Profit Margin	39.50%	38.78%	26.09%	22.36%	25.65%
Free Cash Flow Margin	42.51%	30.91%	13.08%	31.39%	-2.98%
EBITDA	50.9	37.51	15.71	9.3	7.98
EBITDA Margin	59.25%	57.97%	39.91%	34.10%	40.25%
D&A For EBITDA	0.23	0.18	0.15	0.15	0.12
EBIT	50.68	37.32	15.56	9.15	7.86
EBIT Margin	58.98%	57.68%	39.52%	33.54%	39.63%
Effective Tax Rate	33.08%	32.94%	33.52%	34.04%	33.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.